Gujarat Themis Biosyn Limited — Important, 13-06-2025: General Updates

Gujarat Themis Biosyn has announced a board meeting and withdrawn its earlier merger plan with Themis Medicare. The company will focus on its core fermentation-based pharmaceutical intermediates and active pharmaceutical ingredients business, targeting organic capacity expansion, strategic collaborations, and potential inorganic growth. This strategic pivot highlights management’s confidence in driving stronger value through core strengths amid evolving market conditions.